cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2008; 52:655-666, doi:10.1016/j.jacc.2008.05.019
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Figures
Right arrow View Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Zhou, G.
Right arrow Articles by Cai, L.
PubMed
Right arrow Articles by Zhou, G.
Right arrow Articles by Cai, L.

Metallothionein Suppresses Angiotensin II–Induced Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activation, Nitrosative Stress, Apoptosis, and Pathological Remodeling in the Diabetic Heart

Guihua Zhou, MD, PhD*, Xiaokun Li, MD, PhD, David W. Hein, PhD{dagger}, Xilin Xiang, MD, PhD*, James P. Marshall, BS*, Sumanth D. Prabhu, MD*,{ddagger},||,* and Lu Cai, MD, PhD*,{dagger},§,*

* Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky
{dagger} Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky
{ddagger} Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, Kentucky
§ Department of Radiation Oncology, University of Louisville School of Medicine, Louisville, Kentucky
|| Medical Service, Louisville Veterans Affairs Medical Center, Louisville, Kentucky
Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Wenzhou, China.

Manuscript received January 14, 2008; revised manuscript received April 30, 2008, accepted May 5, 2008.

* Reprint requests and correspondence: Dr. Lu Cai, 511 South Floyd Street, MDR 533, Louisville, Kentucky 40202. or Dr. Sumanth D. Prabhu (Email: sprabhu{at}louisville.edu).

Objectives: We evaluated metallothionein (MT)-mediated cardioprotection from angiotensin II (Ang II)–induced pathologic remodeling with and without underlying diabetes.

Background: Cardiac-specific metallothionein-overexpressing transgenic (MT-TG) mice are resistant to diabetic cardiomyopathy largely because of the antiapoptotic and antioxidant effects of MT.

Methods: The acute and chronic cardiac effects of Ang II were examined in MT-TG and wild-type (WT) mice, and the signaling pathways of Ang II–induced cardiac cell death were examined in neonatal mouse cardiomyocytes.

Results: Acute Ang II administration to WT mice or neonatal cardiomyocytes increased cardiac apoptosis, nitrosative damage, and membrane translocation of the nicotinamide adenine dinucleotide phosphate oxidase (NOX) isoform p47phox. These effects were abrogated in MT-TG mice, MT-TG cardiomyocytes, and WT cardiomyocytes pre-incubated with peroxynitrite or superoxide scavengers and NOX inhibitors, suggesting a critical role for NOX activation in Ang II–mediated apoptosis. Prolonged administration of subpressor doses of Ang II (0.5 mg/kg every other day for 2 weeks) also induced apoptosis and nitrosative damage in both diabetic and nondiabetic WT hearts, but not in diabetic and nondiabetic MT-TG hearts. Long-term follow-up (1 to 6 months) of both WT and MT-TG mice after discontinuing Ang II administration revealed progressive myocardial fibrosis, hypertrophy, and dysfunction in WT mice but not in MT-TG mice.

Conclusions: Metallothionein suppresses Ang II–induced NOX-dependent nitrosative damage and cell death in both nondiabetic and diabetic hearts early in the time course of injury and prevents the late development of Ang II–induced cardiomyopathy.

Key Words: metallothionein • diabetic cardiomyopathy • angiotensin II • cardiomyocyte apoptosis • NADPH oxidase • nitrosative damage

Abbreviations and Acronyms
  Ang II = angiotensin II
  ANOVA = analysis of variance
  CAT-TG = catalase-overexpressing transgenic
  CTGF = connective tissue growth factor
  ET = endothelin
  LV = left ventricle/ventricular
  MT = metallothionein
  MT-TG = cardiac-specific, metallothionein-overexpressing transgenic
  NOX = nicotinamide adenine dinucleotide phosphate oxidase
  NT = nitrotyrosine
  PAI = plasminogen activator inhibitor
  RNS = reactive nitrogen species
  ROS = reactive oxygen species
  STZ = streptozotocin
  TNF = tumor necrosis factor
  TUNEL = terminal transferase dUTP nick end labeling
  WT = wild type




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
W. C. De Mello
Metallothionein Reverses the Harmful Effects of Angiotensin II on the Diabetic Heart
J. Am. Coll. Cardiol., August 19, 2008; 52(8): 667 - 669.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home